Total Payments
$75,355
2024 Payments
$1,815
Companies
23
Transactions
608
Medicare Patients
1,633
Medicare Billing
$106,093
Payment Breakdown by Category
Other$49,615 (65.8%)
Food & Beverage$11,408 (15.1%)
Travel$9,140 (12.1%)
Consulting$4,547 (6.0%)
Education$644.61 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,615 | 23 | 65.8% |
| Food and Beverage | $11,408 | 549 | 15.1% |
| Travel and Lodging | $9,140 | 23 | 12.1% |
| Consulting Fee | $4,547 | 2 | 6.0% |
| Education | $644.61 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $50,617 | 207 | $0 (2024) |
| ViiV Healthcare Company | $20,686 | 195 | $0 (2024) |
| Janssen Biotech, Inc. | $930.73 | 63 | $0 (2023) |
| Merck Sharp & Dohme LLC | $810.77 | 43 | $0 (2024) |
| Janssen Products, LP | $698.55 | 8 | $0 (2021) |
| Novo Nordisk Inc | $349.71 | 22 | $0 (2024) |
| Theratechnologies Inc. | $262.09 | 14 | $0 (2024) |
| AbbVie, Inc. | $158.49 | 8 | $0 (2017) |
| Allergan Inc. | $148.67 | 10 | $0 (2018) |
| Lilly USA, LLC | $124.16 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,815 | 67 | ViiV Healthcare Company ($1,151) |
| 2023 | $5,343 | 79 | ViiV Healthcare Company ($4,421) |
| 2022 | $11,033 | 81 | ViiV Healthcare Company ($10,401) |
| 2021 | $1,860 | 62 | Gilead Sciences, Inc. ($1,416) |
| 2020 | $5,358 | 39 | Gilead Sciences, Inc. ($4,988) |
| 2019 | $26,768 | 93 | Gilead Sciences, Inc. ($21,995) |
| 2018 | $15,393 | 74 | Gilead Sciences, Inc. ($14,667) |
| 2017 | $7,784 | 113 | Gilead Sciences Inc ($6,311) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: HIV | ||||||
| 12/19/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $94.45 | General |
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: HIV | ||||||
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: HIV | ||||||
| 12/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: HIV | ||||||
| 12/02/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: HIV | ||||||
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 11/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: HIV | ||||||
| 11/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: HIV | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.48 | General |
| 11/07/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $107.72 | General |
| 11/07/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: HIV | ||||||
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: HIV | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: HIV | ||||||
| 10/17/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: HIV | ||||||
| 10/08/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: HIV | ||||||
| 09/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: HIV | ||||||
| 09/24/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: HIV | ||||||
| 09/11/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: HIV | ||||||
| 09/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: HIV | ||||||
| 08/29/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $140.13 | General |
| 08/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 347 | 551 | $60,735 | $31,307 |
| 2022 | 9 | 453 | 645 | $53,940 | $27,416 |
| 2021 | 15 | 538 | 666 | $54,650 | $33,081 |
| 2020 | 10 | 295 | 368 | $36,060 | $14,289 |
Total Patients
1,633
Total Services
2,230
Medicare Billing
$106,093
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 165 | $28,875 | $14,382 | 49.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 91 | $21,385 | $11,494 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 55 | $6,600 | $3,094 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 229 | $3,435 | $1,907 | 55.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $440.00 | $431.20 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 169 | $29,575 | $14,485 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 43 | $10,105 | $5,455 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 64 | $7,680 | $4,121 | 53.7% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 53 | 61 | $1,830 | $1,749 | 95.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 126 | 210 | $3,150 | $609.96 | 19.4% |
| 90471 | Administration of vaccine | Office | 2022 | 48 | 56 | $894.72 | $571.20 | 63.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $330.00 | $325.20 | 98.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 16 | 18 | $180.00 | $54.96 | 30.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 13 | $195.00 | $44.97 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 138 | $24,150 | $13,540 | 56.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 46 | $10,810 | $5,981 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $2,880 | $2,927 | 101.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $1,980 | $1,994 | 100.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 53 | 55 | $1,650 | $1,650 | 100.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $1,750 | $1,619 | 92.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 30 | $3,600 | $1,565 | 43.5% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 41 | 41 | $1,230 | $1,230 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 49 | 50 | $1,500 | $945.40 | 63.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 30 | 31 | $930.00 | $563.98 | 60.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 92 | 154 | $2,310 | $459.00 | 19.9% |
About Dr. Mark Watkins, DO
Dr. Mark Watkins, DO is a Adult Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336226166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Watkins, DO has received a total of $75,355 in payments from pharmaceutical and medical device companies, with $1,815 received in 2024. These payments were reported across 608 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,615).
As a Medicare-enrolled provider, Watkins has provided services to 1,633 Medicare beneficiaries, totaling 2,230 services with total Medicare billing of $106,093. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Medicine
- Location Philadelphia, PA
- Active Since 11/01/2006
- Last Updated 05/26/2009
- Taxonomy Code 207QA0505X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336226166
Products in Payments
- Truvada (Drug) $30,479
- Descovy (Drug) $13,698
- CABENUVA (Biological) $9,377
- APRETUDE (Biological) $5,783
- PREZCOBIX (Drug) $737.39
- SYMTUZA (Drug) $659.52
- DOVATO (Drug) $658.26
- PIFELTRO (Drug) $452.58
- ISENTRESS (Drug) $344.38
- EGRIFTA (Drug) $262.09
- Symtuza (Drug) $232.37
- TRIUMEQ (Drug) $196.93
- Ozempic (Drug) $157.39
- Biktarvy (Drug) $119.38
- RUKOBIA (Drug) $110.54
- MOUNJARO (Drug) $108.09
- JULUCA (Drug) $101.80
- Epclusa (Drug) $96.93
- Androgel (Drug) $93.91
- Trintellix (Drug) $78.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Medicine Doctors in Philadelphia
Mr. Peter Honig, Do, DO
Adult Medicine — Payments: $187,100
Adult Medicine $187,100
Dr. Harvey Spector, D.o, D.O
Adult Medicine — Payments: $21,425
Adult Medicine $21,425
Dr. James Tweedy, D.o, D.O
Adult Medicine — Payments: $1,969
Adult Medicine $1,969
Dr. Amy Orloff-Fine, Do, DO
Adult Medicine — Payments: $1,901
Adult Medicine $1,901
Dr. Agnes Simmons, M. D, M. D
Adult Medicine — Payments: $1,723
Adult Medicine $1,723
Paul Le
Adult Medicine — Payments: $1,163
Adult Medicine $1,163